Patents Assigned to ONCOSOL LIMITED
  • Publication number: 20250170123
    Abstract: Pharmaceutical compositions comprising oil as a vehicle, a suspending agent, and a surfactant are disclosed to be used in conjunction with temozolomide.
    Type: Application
    Filed: January 17, 2025
    Publication date: May 29, 2025
    Applicant: ONCOSOL LIMITED
    Inventors: VIJAY PATEL, SANDIP MEHTA, MANISHKUMAR UMRETHIA, JAYANTA MANDAL
  • Publication number: 20240374516
    Abstract: A ready to use oral pharmaceutical suspension that includes dasatinib or a pharmaceutically acceptable salt thereof, a suspending agent, a wetting agent, a binder or filler, a buffering agent in an amount sufficient to provide a pH of from about 4 to about 8 and water.
    Type: Application
    Filed: July 23, 2024
    Publication date: November 14, 2024
    Applicant: ONCOSOL LIMITED
    Inventors: SANDIP MEHTA, MANISHKUMAR UMRETHIA, JAYANTA MANDAL
  • Patent number: 12083222
    Abstract: Disclosed herein are pharmaceutical compositions in the form of a suspension for oral delivery. Some embodiments provide a pharmaceutical composition in the form of a suspension for oral delivery comprising an anti-cancer active pharmaceutical ingredient; water; a suspending agent; a buffering agent; and one or more of a wetting agent and a binder/filler. In some embodiments, the anti-cancer active pharmaceutical ingredient is selected from ibrutinib, nilotinib, dasatinib, sunitinib, sorafenib, erlotinib, and capecitabine.
    Type: Grant
    Filed: August 16, 2019
    Date of Patent: September 10, 2024
    Assignee: ONCOSOL LIMITED
    Inventors: Sandip Mehta, Manish Kumar Umrethia, Jayanta Mandal